Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Búsqueda de fabricantes de equipos de diagnóstico en el sector de biotecnología para participar en un proyecto Eurostars y desarrollar pruebas de detección rápida de la tuberculosis bovina en alto volumen

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDUK20180207001
Publicado:
08/02/2018
Caducidad:
16/02/2018
Resumen:
Una pyme británica del sector de biotecnología ha desarrollado una prueba de diagnóstico rápido de bacterias vivas que causan la tuberculosis bovina (bTB) no solo en ganado sino también en otras especies de animales. Esta prueba permitirá un importante ahorro de costes y evitará sacrificios innecesarios en las industrias cárnica y láctea. La empresa va a lanzar kits de diagnóstico basados en esta tecnología y busca fabricantes de equipos de diagnóstico en el sector de biotecnología en Holanda y Dinamarca para participar en un proyecto Eurostars y mejorar el kit de diagnóstico. La fecha límite de la convocatoria es el 1 de marzo de 2018 y el plazo para presentar expresiones de interés finaliza el 16 de febrero.

Details

Tittle:
Biotech, diagnostic equipment manufacturers sought for Eurostars project to develop high volume, rapid, bovine tuberculosis tests.
Summary:
A UK biotech SME has developed a unique, rapid diagnostic test for live bacteria that cause bovine tuberculosis (bTB) not just in cattle but many other animal species. It should save significant costs and unnecessary culling in global meat and dairy industries. Just launching the product in single unit test form the company seeks biotech manufacturing partners in the Netherlands or Denmark to join a development project to scale-up the test in a Eurostars funded development project.
Description:
The incidence of bovine tuberculosis (bTB) represents a real cost to meat and dairy industries across the world. Although it appears to have been eradicated in most of Europe, pockets of the disease still stubbornly persist in wildlife in countries such as the UK, USA and Canada posing a risk to cattle, sheep and goat herds requiring stringent control measures in all countries.

Diagnostic testing for the disease is a critical factor in these measures but current skin tests based on an animal´s immune response take 3 days to produce results and, more worryingly, such tests are known to miss about 20% of the animals. Other, more accurate tests require many days, up to 3 months, to produce meaningful results meaning that major costs are incurred as the disease spreads through whole herds before it is detected.

A UK biotech SME has successfully developed a unique test directly detecting live bacteria in blood or milk. It is fast and highly sensitive with the potential to produce results within 6 hours.

The company is about to launch diagnostic products based on this technology which it will manufacture as single test kits. Significant international interest from governments, regulatory authorities and primary meat and dairy producers is already being shown which indicates a requirement to scale this test to cope with high volume demands. The UK company therefore wishes to work with a biotech diagnostic equipment manufacturer to develop a high volume test system utilising this technology.

It is intended to make an application for Eurostars support by the closing date of 1st March 2018, so the UK company seeks a biotech diagnostics manufacturing partner in either the Netherlands or Denmark. The partner should be able to introduce ideas, processes and automation technologies that would enable testing to be scaled-up from the existing single tube test to the equivalent of a 96 plate array. Expressions of interest are required by Friday 16th February 2018.
Advantages and Innovations:
· Fast response with results available in 6 - 8 hours (i.e. same day) compared to between 1 - 3 months for the current "gold standard" tests. This ensures early detection of infection thus enabling far more effective treatment and control.

· Sensitivity and specificity better than current "gold standard" tests.

· Simple to operate and cost effective compared to current "gold standard" tests, offering attractive sales margins.

· Technology has been developed from university research and has been scientifically peer reviewed ensuring its validity.

· The core technology is patent protected ensuring any collaboration partner can enjoy competitive advantage in their markets.
Stage of Development:
Proposal under development
Technical Specification or Expertise Sought:
From their experience and expertise, the partner should be able to introduce ideas, processes and automation technologies that would enable the bio-technology to be scaled-up from the existing single tube test to the equivalent of a 96 plate array test.
IPR Status:
Secret Know-how,Patent(s) applied for but not yet granted,Exclusive Rights
Comments Regarding IPR Status:
Although based on technology originally developed and patented over twenty years ago, this was significantly revised and refined with a new patent being filed in 2013 for UK with extension to Europe and USA in April 2016. Exclusive exploitation rights for this intellectual property have been granted to the UK company.

Partner sought

Partner Sought:
The partner needs to be a company engaged in the manufacture of medical or veterinary diagnostic equipment. They need to be located in either the Netherlands or Denmark and keen to participate in a Eurostars supported development project. From their experience and expertise, the partner should be able to introduce ideas, processes and automation technologies that would enable the bio-technology to be scaled-up from the existing single tube test to the equivalent of a 96 plate array test.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
Industry SME <= 10
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
French
Italian
Spanish

Dissemination

Restrict dissemination to specific countries:
Denmark
Netherlands

Programme-call

Framwork Programme:
Eureka
Coordinator Required:
No
Deadline for Call:
01/03/2018
Weblink to the Call: